Michael Decourcey, MD
Ophthalmology · Mount Pleasant, SCNPI 1477042711
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (43.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Bausch & Lomb Americas Inc. accounts for 65.0% of it on its own, with 25 other manufacturers making up the rest. 2025 is the largest year on record at $10,249, more than ten times the $500 reported in 2022. Among ophthalmology clinicians in SC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 139 payments — averaging $98.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb Americas Inc.$9K
- Tarsus Pharmaceuticals, Inc.$756
- Johnson & Johnson Surgical Vision, Inc.$582
- Carl Zeiss Meditec USA, Inc.$551
- Alcon$547
- Sun Pharmaceutical Industries Inc.$402
- plus $2K from 20 others
What the payments were for
- Consulting fees$6,00044%
- Travel & lodging$2,27617%
- Food & beverage$5,42840%
- Education$60%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb Americas Inc. | 20 | $8,915 |
| Tarsus Pharmaceuticals, Inc. | 25 | $756 |
| Johnson & Johnson Surgical Vision, Inc. | 9 | $582 |
| Carl Zeiss Meditec USA, Inc. | 5 | $551 |
| Alcon | 13 | $547 |
| Sun Pharmaceutical Industries Inc. | 17 | $402 |
| Glaukos Corporation | 7 | $388 |
| NEW World Medical,inc. | 3 | $259 |
| Oyster Point Pharma, Inc. | 7 | $149 |
| AbbVie | 5 | $122 |
| Genentech USA, Inc. | 1 | $117 |
| Rayner Intraocular Lenses Limited | 5 | $114 |
| Biotissue Holdings Inc. | 1 | $113 |
| Amgen | 1 | $111 |
| Alimera Sciences, Inc. | 1 | $107 |
| Harrow Eye, LLC | 4 | $104 |
| Mallinckrodt Hospital Products Inc. | 5 | $103 |
| Nova Eye, Inc. | 1 | $78 |
| ANI Pharmaceuticals, Inc. | 2 | $44 |
| Carl Zeiss Meditec, Inc. | 1 | $36 |
| Ocular Therapeutix, Inc. | 1 | $25 |
| Dompe US, Inc. | 1 | $23 |
| Thea Pharma Inc. | 1 | $20 |
| Rxsight Inc | 1 | $17 |
| Sight Sciences, Inc. | 1 | $15 |
| Merck | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Wavelight Refractive Suite$283
- Tecnis IOL$262
- iDoseTR$210
- VisuMax$187
- VERITAS Vision System$157
- XDEMVY$148
- Tecnis Simplicity$145
- CEQUA$140
- VABYSMO$117
- Kahook Dual Blade$114
- Clearpath$114
- Ahmed Glaucoma Valve$114
- Streamline$114
- enVista MX60 IOL$113
- TEPEZZA$111
- Iluvien$107
- CATALYS SYSTEM$105
How this compares
$13,710 in reported general payments places this provider in the 90th percentile of 293 ophthalmology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 13 | $9,330 |
| Latanoprost | 81 | $793 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 22 | $394 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis | $122 | $9,33013 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 293 ophthalmology providers in South Carolina.
Other ophthalmology in Mount Pleasant
- Francisco FolgarMount Pleasant$35K
- Charlene GriceMount Pleasant$7K
- Kerry SolomonMt Pleasant$1.7M
- William ClarkWest Columbia$768K
- George WaringMt Pleasant$645K
- Karolinne RochaCharleston$552K
- Joseph BishopHilton Head Island$136K
- Erik HappMt Pleasant$124K
- Matthew ClaryColumbia$119K
- Kunal KanitkarLexington$83K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.